文献速递冠心病

新型即时检测高敏肌钙蛋白I的临床与分析性能

Clinical and Analytical Performance of a Novel Point-of-Care High-Sensitivity Cardiac Troponin I Assay.
PubMed 文献 · J Am Coll Cardiol · 2024-01-01

这项国际多中心诊断研究纳入1102例急诊急性胸痛患者,评估新型即时检测hs-cTnI-SPINCHIP的性能。结果显示其诊断心肌梗死的AUC为0.94,与中心实验室检测相当,且其0/1小时算法可高效排除和纳入心肌梗死。

要点

  • hs-cTnI-SPINCHIP诊断心肌梗死的AUC为0.94,与现有中心实验室检测相当。
  • 0/1小时算法可排除51%的患者,敏感性和阴性预测值均为100%。
  • 该算法可纳入27%的患者,特异度90.9%,阳性预测值72.9%。

核心结论

  • hs-cTnI-SPINCHIP即时检测具有很高的诊断准确性,其0/1小时算法对心肌梗死的排除和纳入均表现优异。

研究设计与样本

  • 国际多中心诊断研究,纳入1102例急诊急性胸痛成人患者,最终诊断由两名独立心内科医生集中裁定。

主要发现

  • 心肌梗死为214例(19%)患者的最终诊断。
  • hs-cTnI-SPINCHIP的AUC为0.94(95%CI:0.92-0.95),与hs-cTnI-Architect的0.94(95%CI:0.92-0.95)相比P=0.907,与高敏肌钙蛋白T Elecsys的0.93(95%CI:0.91-0.95)相比P=0.305。
  • 就诊时hs-cTnI-SPINCHIP<7 ng/L(若胸痛发作>3小时)或<7 ng/L且0/1小时变化<4 ng/L可排除51%的患者,敏感性和阴性预测值均为100%(95%CI分别为97.7%-100%和99.0%-100%)。
  • hs-cTnI-SPINCHIP≥36 ng/L或0/1小时变化≥11 ng/L可纳入27%的患者,特异度为90.9%(95%CI:88.3%-92.9%),阳性预测值为72.9%(95%CI:66.4%-78.6%)。
  • 不同样本类型(全血、新鲜/冷冻血浆、指尖毛细血管血)之间观察到高度一致性。

关键数值与推荐

  • 排除标准:就诊时hs-cTnI-SPINCHIP<7 ng/L(胸痛发作>3小时)或<7 ng/L且0/1小时变化<4 ng/L。
  • 纳入标准:hs-cTnI-SPINCHIP≥36 ng/L或0/1小时变化≥11 ng/L。

临床怎么用

  • 该即时检测的0/1小时算法可用于急诊胸痛患者快速排除或纳入心肌梗死,支持临床决策。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Point-of-care (POC) high-sensitivity cardiac troponin assays may further accelerate the diagnosis of myocardial infarction (MI). OBJECTIVES: This study sought to assess the clinical and analytical performance of the novel high-sensitivity cardiac troponin I (hs-cTnI)-SPINCHIP POC test. METHODS: Adult patients presenting with acute chest discomfort to the emergency department were enrolled in an international, diagnostic, multicenter study. The final diagnosis was centrally adjudicated by 2 independent cardiologists using all clinical information. We compared the discriminatory performance of hs-cTnI-SPINCHIP with current established central laboratory assays and derived an assay-specific hs-cTnI-SPINCHIP 0/1-hour algorithm. Secondary analyses included sample type comparisons (whole blood, fresh/frozen plasma, and capillary finger prick) and precision analysis. RESULTS: MI was the adjudicated final diagnosis in 214 (19%) of 1,102 patients. Area under the receiver-operating characteristic curve was 0.94 (95% CI: 0.92-0.95) for hs-cTnI-SPINCHIP vs 0.94 (95% CI: 0.92-0.95) for hs-cTnI-Architect (P = 0.907) and 0.93 (95% CI: 0.91-0.95) for high-sensitivity cardiac troponin T Elecsys (P = 0.305). A cutoff <7 ng/L at presentation (if chest pain onset was >3 hours) or <7 ng/L together with a 0/1-hour delta of <4 ng/L ruled out 51% with a sensitivity and negative predictive value of 100% (95% CI: 97.7%-100%) and 100% (95% CI: 99.0%-100%), respectively. A hs-cTnI-SPINCHIP concentration ≥36 ng/L or a 0/1-hour delta ≥11 ng/L ruled in 27% with a specificity and positive predictive value of 90.9% (95% CI: 88.3%-92.9%) and 72.9% (95% CI: 66.4%-78.6%), respectively. Bootstrap internal validation confirmed excellent diagnostic performance. High agreement was observed between different sample types. CONCLUSIONS: The SPINCHIP hs-cTnI POC test has very high diagnostic accuracy. Its assay-specific 0/1-hour algorithm achieved very high sensitivity/negative predictive value and specificity/positive predictive value for rule-out/in MI. (Advantageous Predictors of Acute Coronary Syndromes Evaluation [APACE] Study [APACE]; NCT00470587).

来源:J Am Coll Cardiol,查看原文。版权归原作者所有。

引用

  1. Koechlin, Boeddinghaus, Lopez-Ayala, et al. Clinical and Analytical Performance of a Novel Point-of-Care High-Sensitivity Cardiac Troponin I Assay. J Am Coll Cardiol. 2024. PMID: 39142727. doi:10.1016/j.jacc.2024.05.056

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。